Reaction

Product Commingling reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,034 reports · 6 co-occurring drugs

As of the last recalculation, Product Commingling appears in 1,034 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is FEXOFENADINE HCL (PRR 15.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Fexofenadine Hcl715.315.3
Ibuprofen Tablets, Coated3014.614.6
Ibuprofen Sodium3014.514.5
Sevelamer Carbonate712.312.3
Loratadine And Pseudoephedrine Sulfate410.210.2
Naproxen Sodium Tablet2610.110.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.